AJP - Heart Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (March 16, 2007). doi:10.1152/ajpheart.01415.2006
This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Videos
Right arrow All Versions of this Article:
293/1/H875    most recent
01415.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nanthakumar, K.
Right arrow Articles by Dhopeshwarkar, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nanthakumar, K.
Right arrow Articles by Dhopeshwarkar, R.
Submitted on December 26, 2006
Accepted on March 16, 2007

Optical Mapping of Langendorff Perfused Human Hearts: Establishing a Model for the Study of Ventricular Fibrillation in Humans

Kumaraswamy Nanthakumar1*, Jose Jalife2, Stephane Masse1, Eugene Downar1, Mihaela Pop1, John Asta1, Heather Ross1, Vivek Rao1, Sergey F Mironov3, Elias Sevaptsidis1, Jack M Rogers4, Graham Wright1, and Rajesh Dhopeshwarkar1

1 Medicine, University of Toronto, Toronto, Canada
2 Pharmacology, SUNY Upstate Medical University, Syracuse, New York, United States
3 Pharmacology, SUNY Upstate Medical University, Syracuse, United States; Pharmacology, SUNY Upstate Medical University, Syracuse, New York, United States
4 Biomedical Engineering, Univ of Alabama at Birmingham, Birmingham, Alabama, United States

* To whom correspondence should be addressed. E-mail: k.nanthakumar{at}uhn.on.ca.

The objective of this report was to establish a novel model for the study of ventricular fibrillation (VF) in humans. We adopted the established techniques of optical mapping to human ventricles for the first time to determine whether human VF is the result of wavebreaks and singularity point formation and is maintained by high frequency rotors and fibrillatory conduction. We describe the technique of acquiring optical signals in human hearts during VF, their characteristics and feasibility on possible analyses that could be performed for elucidating mechanisms of human VF. We used explanted hearts from five cardiomyopathic patients who underwent transplantation. The hearts were Langendorff-perfused with Tyrode's solution (95%O2+5%CO2) and the potentiometric dye Di-4-ANEPPS was injected as a bolus into the coronary circulation. The fluorescence was excited at 531nm ± 20nm with a 150 W halogen light source; the emission signal was long pass filtered at 610 nm and recorded with a mapping camera. The delta F/F varied between 2-12%. The average signal to noise ratio was 40 dB. The mean velocity of ventricular fibrillation wavefronts was 0.25±0.04 m/sec. The sub-millimetric spatial resolution (0.65-0.85 mm), activation mapping and transformation of the data to phase based analysis revealed re-entrant, colliding and fractionating wavefronts in human ventricular fibrillation. On many occasions the VF wavefronts were as large as the entire vertical length (8 cm) of the mapping field, suggesting that there a limited number of wavefronts on the human heart during VF. The phase transformation of the optical signals allowed the first demonstration ever of phase singularity point, wavebreaks and rotor formation in human VF. This method provides opportunities for potential analyses toward elucidating the mechanisms of ventricular fibrillation and defibrillation in humans.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.